ECS Botanics Holdings Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

ECS Botanics Holdings şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

-17.3%

Geri Alım Getirisi

Toplam Hissedar Getirisi	-17.3%
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	n/a

Son temettü ve geri alım güncellemeleri

Güncelleme yok

Recent updates

Lacklustre Performance Is Driving ECS Botanics Holdings Ltd's (ASX:ECS) 26% Price Drop

Nov 11

There's No Escaping ECS Botanics Holdings Ltd's (ASX:ECS) Muted Earnings Despite A 38% Share Price Rise

Sep 27

ECS Botanics Holdings Ltd's (ASX:ECS) Shares Lagging The Market But So Is The Business

Aug 12

There Is A Reason ECS Botanics Holdings Ltd's (ASX:ECS) Price Is Undemanding

Apr 03

ECS Botanics Holdings Ltd's (ASX:ECS) Share Price Could Signal Some Risk

Sep 06

ECS Botanics Holdings (ASX:ECS) Is In A Good Position To Deliver On Growth Plans

Feb 24

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: ECS şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: ECS şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

ECS Botanics Holdings Piyasaya Karşı Temettü Getirisi

ECS temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (ECS)	n/a
Pazarın Alt %25'i (AU)	2.6%
Pazarın En İyi %25'i (AU)	6.1%
Sektör Ortalaması (Pharmaceuticals)	2.3%
Analist tahmini (ECS) (3 yıla kadar)	n/a

Önemli Temettü: ECS şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, ECS şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: ECS şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: ECS herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

ECS Botanics Holdings Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

Recent updates

Lacklustre Performance Is Driving ECS Botanics Holdings Ltd's (ASX:ECS) 26% Price Drop

ECS Botanics Holdings Ltd, Annual General Meeting, Nov 21, 2024

There's No Escaping ECS Botanics Holdings Ltd's (ASX:ECS) Muted Earnings Despite A 38% Share Price Rise

ECS Botanics Holdings Ltd Announces Management Appointments

Full year 2024 earnings released: EPS: AU$0.002 (vs AU$0 in FY 2023)

New minor risk - Share price stability

ECS Botanics Holdings Ltd's (ASX:ECS) Shares Lagging The Market But So Is The Business

There Is A Reason ECS Botanics Holdings Ltd's (ASX:ECS) Price Is Undemanding

New minor risk - Profit margin trend

New minor risk - Shareholder dilution

First half 2024 earnings released: EPS: AU$0.001 (vs AU$0.001 loss in 1H 2023)

ECS Botanics Holdings Ltd to Report Q2, 2024 Results on Feb 28, 2024

ECS Botanics Holdings Ltd has completed a Follow-on Equity Offering in the amount of AUD 4.000016 million.

ECS Botanics Holdings Ltd's (ASX:ECS) Share Price Could Signal Some Risk

Full year 2023 earnings released: EPS: AU$0 (vs AU$0.001 loss in FY 2022)

New minor risk - Financial data availability

ECS Botanics Holdings Ltd, Annual General Meeting, Oct 26, 2023

ECS Botanics Holdings Ltd Launches Investor Hub

First half 2023 earnings released: AU$0.001 loss per share (vs AU$0.003 loss in 1H 2022)

ECS Botanics Holdings Ltd Announces Resignation of Mr. Alex Keach as Head of Corporate Development and an Executive Director

No independent directors

Blue Buffalo Pty Ltd has entered into a binding share purchase agreement to acquire ECS Botanics Pty Ltd from ECS Botanics Holdings Ltd (ASX:ECS) for AUD 3 million.

Full year 2022 earnings released: AU$0.001 loss per share (vs AU$0.006 loss in FY 2021)

ECS Botanics Holdings Ltd, Annual General Meeting, Oct 26, 2022

MD & Executive Director recently bought AU$90k worth of stock

ECS Botanics Holdings Ltd Announces Change of Managing Director

ECS Botanics Holdings Ltd Announces Executive Changes

No independent directors

Founder exercised options to buy AU$510k worth of stock.

Full year 2021 earnings released: AU$0.006 loss per share (vs AU$0.009 loss in FY 2020)

ECS Botanics Holdings Ltd Launches Innovative range of 30ml Terpene Blends

ECS Botanics Holdings Ltd Appoints Nan Maree Schoerie as Director

ECS Botanics Holdings (ASX:ECS) Is In A Good Position To Deliver On Growth Plans

First half 2021 earnings released: AU$0.005 loss per share (vs AU$0.008 loss in 1H 2020)

ECS Botanics Holdings Ltd Appoints Paul Hanrahan as Site & Cultivation Manager

ECS Botanics Holdings Ltd (ASX:ECS) signed a binding term sheet to acquire Murray Meds Pty Ltd, Flowerday Farms Pty Ltd and Flowerday Land Property from Flowerday Holdings Pty Ltd for AUD 7.5 million.

ECS Botanics Holdings Ltd Enters into Term Sheet with Medipharm Labs

ECS Botanics Holdings Ltd announced that it expects to receive AUD 4 million in funding

ECS Provides Medicinal Cannabis Project and Regulatory Update

ECS Botanics Holdings Ltd Appoints Damian Wood as Director of Medicinal Cannabis Production

ECS Botanics Holdings Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.75 million.

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi

Hissedarlara Ödenen Kazanç

Hissedarlara Nakit Ödeme

Güçlü temettü ödeyen şirketleri keşfedin